Status:
UNKNOWN
High Flux Hemodialysis Thrice Versus Once
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
Mrs. Hsiu-Chin Lee Kidney Research Fund
Conditions:
End-Stage Renal Disease
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
To investigate the influence of different dialysis frequencies on the outcome of end-stage renal disease patients undergoing chronic hemodialysis therapy.
Detailed Description
This study will be conducted in the HD center at NTUH. Patients undergoing chronic HD for at least 6 months will be evaluated for eligibility. Patients with previous adverse reactions to FX series dia...
Eligibility Criteria
Inclusion
- ESRD patients under regular thrice weekly HD for more than 3 months in NTUH HD center.
- Age: 18\~80 years old.
- Blood flow during dialysis ≧ 250ml/min
Exclusion
- Previous allergy to heparin or FX series dialyzer (FX-60, FX-80, FX-100)
- Pre-dialysis systolic blood pressure ≦ 100mmHg (2week prior to enrollment)
- Bacteremia, myocardial infarction or stroke in previous 3 months.
- Known diagnosis with dialysis related amyloidosis
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00714662
Start Date
June 1 2008
End Date
March 1 2009
Last Update
July 14 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100